BioSpace News Archive

Pharm Country

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing

Medunik USA is proud to announce today that Siklos® (hydroxyurea), an FDA-approved orphan drug, is now available in 1,000 mg triple-scored tablets to help optimize dosing.

November 19, 2018
·
4 min read
Job Trends

PDL BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference

The session will be webcast live and will occur on Tuesday, November 27, 2018, at 1:50 p.m. EST.

November 19, 2018
·
2 min read
Policy

BioPharma Services, Inc. Receives a Stamp of Approval by the World Health Organization

BioPharma received a status of Compliance valid through to the 1st of January 2021.

November 19, 2018
·
2 min read
Job Trends

New Holiday Cookbook Addresses Diet and Nutrition Needs of Those with Kidney Disease

DaVita Kidney Care releases ‘Holiday Gatherings’ Cookbook

November 19, 2018
·
3 min read
Business

Khiron Life Sciences Achieves Milestone With Additional Cultivation Quotas From The Colombian Technical Quotas Group

Quotas represent progress towards cultivating strains for commercial purposes in Q1 of 2019

November 19, 2018
·
4 min read
Business

RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.

Reflects Company’s Transition to Develop Groundbreaking Immuno-Oncology Therapeutics

November 19, 2018
·
3 min read
Genetown

Generation Bio to Present at the 2018 Evercore ISI Healthcare Conference

Generation Bio today announced that the company will present at the Evercore ISI Healthcare Conference in Boston, MA.

November 19, 2018
·
1 min read
Genetown

ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 2018 American Society of Hematology (ASH) Annual Meeting

Presentation highlights clinical data in patients with relapsed or refractory hematologic malignancies

November 19, 2018
·
5 min read
Biotech Bay

Two Pore Guys Receives $2.8M Grant to Develop Sensitive, Low-Cost Molecular Diagnostic Tests for Tuberculosis

Goal of Bill & Melinda Gates Foundation Grant Is to Improve TB Care in Resource-Poor Settings

November 19, 2018
·
3 min read
Drug Development

Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Compared with PLD did not meet the prespecified primary endpoints of overall survival or progression-free survival in patients with platinum-resistant or -refractory ovarian cancer.

November 19, 2018
·
21 min read